Predictive Analytics in Clinical Trials: Data-Driven Decisions

 

The pharmaceutical and biotech sectors remain beset by unprecedented challenges in getting innovative treatments to market. With trial expenses running a projected $1.3 billion per approved drug and failure rates of more than 90%, there has never been a greater imperative to make wiser, data-informed choices. Enter predictive analytics in clinical trials, a revolutionary method that applies artificial intelligence to change the face of research study design, execution, and analysis.

The Traditional Clinical Trial: Mess of Inefficiency

To appreciate the scale of the AI-driven revolution, it's important first to understand the limitations of the conventional clinical trial model. For years, the process has been notoriously inefficient. A single drug can take years & billions of $ to bring to market, with a significant portion of that time & expense consumed by clinical trials. Historical outcomes, incomplete data sets, and even educated guesswork inform many of its growing pains. 

Key roadblocks in the traditional process include:

Suboptimal Trial Design: Trial protocols were sometimes inflexibly designed from the outset as a ‘one-size-fits-all’ approach. Protocols that are too rigid may waste time and money if interim results recommend a different approach.

Patient Recruitment Hurdles: Recruitment & identifying the right patients have long been one of the biggest bottlenecks in drug development. Poor patient selection not only slows down trials but is a leading contributor to their failure. Researchers struggled to find homogeneous patient groups who were most likely to respond to a specific therapy.

High Failure Rates: As mentioned above; most drugs that enter clinical trials fail to reach the market. The failures can occur at any phase of a trial, often due to unforeseen safety issues or a great lack of efficacy that could've easily been predicted with the help of clinical trial data analytics solutions.

Data Overload: From genomic sequences & electronic health records (EHRs) to imaging & real-world evidence (RWE), modern trials produce a vast amount of complex data. It is nearly impossible to manually analyze this data in order to make timely decisions.

The consequences of these inefficiencies are not only increased costs but also delayed access to life-saving treatments for patients.

What is Predictive Analytics?

Predictive analytics is the transition from hindsight to foresight. It uses statistical algorithms, machine learning (ML), and historical data to predict future outcomes. In clinical research, it extracts patterns from complex and heterogeneous datasets to drive insights, make predictions, and allow organizations to take action. AI in clinical research transforms raw data into a strategic asset.

The leap from raw data to actionable recommendations can be understood with a continuum of analytical skills:

Descriptive Analytics (What happened?): This is the base layer, involving dashboards and reports that summarize retrospective data, for example, patient recruitment rate or adverse events of a previous quarter. It provides a meaningful representation of things that happened in the past.

Diagnostic Analytics (Why did it happen?): The next level of analytics begins to uncover the root causes of what is happening in the data. For instance, if a trial site is underperforming with respect to enrollment, diagnostic analytics might reveal the reason, such as the inclusion criteria are too restrictive or that the demographics of the local patient population don't match the target population for the trial.

Predictive Analytics (What is likely to happen?): This is one of those inflection points wherein AI in decision-making begins to reach its full potential. Using machine learning algorithms trained on deep historical datasets, AI-augmented clinical studies software can predict future events with tremendous accuracy. Predictive analytics in clinical trials can detect patients at high risk of discontinuation, estimate times of enrollment, or calculate the probabilities of a drug intervention meeting its primary endpoints.

Prescriptive Analytics (What should we do about it?): Most developed stage, prescriptive analytics, extends beyond prediction to suggest definitive action. In instances where a model forecasts a high likelihood of a specified adverse event, it may suggest different dosages or more frequent monitoring for a specified subgroup of patients. This is the pinnacle of data-informed decision-making.

With each stage of the continuum, clinical organizations can develop a strong clinical trial data analytics solutions platform that helps predict & hyper-optimize every aspect of the trial.

AI-Powered Predictive Analytics: Key Benefits

Optimizing Trial Design & Protocols

A successful trial begins with a robust and feasible protocol. AI is instrumental in getting this right from the very start.

Predictive Feasibility: Clinical trial predictive modeling can virtually simulate trial performance even before the first patient is enrolled. Using predictive analytics in clinical trials, research teams can forecast the influence of protocol design on patient burden, site efficiency, and overall cost. This pre-planning capability enables the avoidance of expensive amendments and enrollment setbacks later.

Read More